YXYujun Xu

Yujun Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yujun Xu has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sludge-induced acute pancreatitis is linked to lower cholecystectomy rates than gallstone pancreatitis

    by Max Ole Hubert, Yujun Xu, Maria Valeria Demattè, Arlett Schäfer, Katarzyna Osokin, Katharina Bretthauer, Eric Hohmann, Mali Junge, Mahmood Ahmad, Michal Żorniak, et al.

  • Open Access

    A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial

    by G.-E. Schuebbe, Y. Xu, L.H. Lindner, D. Di Gioia, S. Abdel-Rahman, W.G. Kunz, T. Roshchyna, R. Fenderle, V. Bücklein, P. Reichardt, et al.

  • Open Access

    Common Practice of Percutaneous Drainage in Necrotising Pancreatitis—A Multicentre Retrospective Study (DRACULA)

    by Marlies Vornhülz, Simon Sirtl, Yujun Xu, Sarah Klauss, Elisabeth Orgler‐Gasche, Mihailo Bezmarevic, Milan Jovanovic, Claudio Ricci, Michael Fernandez Y. Viesca, Marianna Arvanitakis, et al.

    Background and Aims: Acute necrotising pancreatitis carries high mortality, especially if infected necrosis occurs. While percutaneous drainage may be required when internal drainage is not feasible, reliable guidelines for managing percutaneous drains are lacking. This study aimed to assess the common practice of percutaneous drainage therapy for infected pancreatic necrosis. Methods: This retrospective study among 29 tertiary care centres included all patients hospitalised for necrotising acute pancreatitis from 01/2016 until 12/2022 with at least one percutaneous drain. The length of hospital stay was the primary endpoint, with mortality as the secondary endpoint. Between‐group comparisons were conducted using the ratio of restricted mean survival time (RMST) after adjusting for confounders. Results: 585 patients (67% male) from 29 tertiary care centres in 15 countries in Europe, Canada and Bolivia were included in the analysis. Length of hospitalisation or mortality did not differ between the flushed ( n = 398) and non‐flushed groups (RMST ratio 1.04, p ‐value = 0.42 and RMST ratio 1.05, p ‐value = 0.1 respectively). Mortality was significantly lower in those patients who received a combination of percutaneous and internal drains (dual‐modality drainage, n = 243) as compared to those who received percutaneous drains only (RMST ratio 1.05, p ‐value = 0.01). Flushing with antibiotics as compared to saline was not associated with shorter length of hospital stay or lower mortality (RMST ratio 0.98, p ‐value = 0.78 and 0.97, p ‐value = 0.48 respectively). Conclusions: This study reveals notable differences in therapeutic concepts and flushing management for percutaneous drains. While flushing itself was not associated with a shorter length of hospitalisation or lower in‐hospital mortality, a lower mortality was observed when internal and percutaneous drainage were used in combination. Clinical Trial Registration: The study was prospectively registered in the German Clinical Trials Register (Deutsches Register Klinischer Studien, DRKS) under the registration number DRKS00032231.


  • Open Access

    Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?

    by Yujun Xu, Tobias Herold, Ulrich Robert Mansmann

    Yujun Xu, Tobias Herold, Ulrich Robert Mansmann; Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?, Bl

  • Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial

    by Rolf D. Issels, Stefan Boeck, Uwe Pelzer, Ulrich Mansmann, Pirus Ghadjar, Lars H. Lindner, Markus Albertsmeier, Martin K. Angele, Michael Schmidt, Yujun Xu, et al.


  • Open Access

    Validating the knowledge bank approach for personalized prediction of survival in acute myeloid leukemia: a reproducibility study

    by Yujun Xu, Ulrich Mansmann

    Reproducibility is not only essential for the integrity of scientific research but is also a prerequisite for model validation and refinement for the future application of predictive algorithms. However, reproducible research is becoming increasingly challenging, particularly in high-dimensional genomic data analyses with complex statistical or algorithmic techniques. Given that there are no mandatory requirements in most biomedical and statistical journals to provide the original data, analytical source code, or other relevant materials for publication, accessibility to these supplements naturally suggests a greater credibility of the published work. In this study, we performed a reproducibility assessment of the notable paper by Gerstung et al. (Nat Genet 49:332–340, 2017) by rerunning the analysis using their original code and data, which are publicly accessible. Despite an open science setting, it was challenging to reproduce the entire research project; reasons included: incomplete data and documentation, suboptimal code readability, coding errors, limited portability of intensive computing performed on a specific platform, and an R computing environment that could no longer be re-established. We learn that the availability of code and data does not guarantee transparency and reproducibility of a study; paradoxically, the source code is still liable to error and obsolescence, essentially due to methodological and computational complexity, a lack of reproducibility checking at submission, and updates for software and operating environment. The complex code may also hide problematic methodological aspects of the proposed research. Building on the experience gained, we discuss the best programming and software engineering practices that could have been employed to improve reproducibility, and propose practical criteria for the conduct and reporting of reproducibility studies for future researchers.


  • Open Access

    Validating the Knowledge Bank Approach for Personalized Prediction of Survival in Acute Myeloid Leukemia: a Reproducibility Study

    by Yujun Xu, Ulrich Mansmann

    Reproducibility is not only essential for the integrity of scientific research, but is also a prerequisite of model validation and refinement for future application of (predictive) algorithms. However, reproducible research is becoming increasingly challenging, particularly in high-dimensional genomic data analyses with complex statistical or algorithmic techniques. Given that there are no mandatory requirements in most biomedical and statistical journals to provide the original data, analytical source code, or other relevant materials for publication, accessibility to these supplements naturally suggests a greater credibility of published work. In this study, we performed a reproducibility assessment of the notable paper by Gerstung et al. published in Nature Genetics (2017) by rerunning the analysis using their original code and data, which are publicly accessible. Despite a perfect open science setting, it was challenging to reproduce the entire research project; reasons included coding errors, suboptimal code legibility, incomplete documentation, intensive computations, and an R computing environment that could no longer be re-established. We learn that availability of code and data does not guarantee transparency and reproducibility of a study; in contrast, the source code is still liable to error and obsolescence, essentially due to methodological complexity, lack of editorial reproducibility checking at submission, and updates of software and operating environment. Building on the experience gained, we propose practical criteria for the conduct and reporting of reproducibility studies for future researchers.


  • Open Access

    Ferumoxytol-β-glucan Inhibits Melanoma Growth via Interacting with Dectin-1 to Polarize Macrophages into M1 Phenotype

    by Xinghan Liu, Yujun Xu, Yi Li, Yuchen Pan, Shuli Zhao, Yayi Hou

    Background: Regulating the polarization of macrophages to antitumor M1 macrophages is a promising strategy for overcoming the immunosuppression of the tumor microenvironment for cancer therapy. Ferumoxytol (FMT) can not only serve as a drug deliver agent but also exerts anti-tumor activity. β-glucan has immuno-modulating properties to prevent tumor growth. Thus, a nanocomposite of FMT surface-coated with β-glucan (FMT-β-glucan) was prepared to explore its effect on tumor suppression.